Nobivac Lyme

Manufacturer: Intervet/Schering-Plough Animal Health

Borrelia Burgdorferi Bacterin

Product Description

Nobivac* Lyme bacterin contains two inactivated isolates of Borrelia burgdorferi. This bacterin is for the vaccination of healthy dogs as an aid in the prevention of subclinical arthritis caused by Borrelia burgdorferi.

Nobivac Lyme Dosage And Administration

Shake well. Using aseptic technique, inject 1 mL (1 dose) subcutaneously into healthy dogs at 8 weeks of age or older. Revaccinate with 1 mL 2 to 4 weeks after initial vaccination. Two doses are required for primary immunization. Annual revaccination with one dose is recommended.

Precautions

- Store at 2° - 7°C.

- Do not freeze.

- Do not mix with other vaccines.

- Use new, non-chemically sterilized needles and syringes.

Warnings

- Contains gentamicin and amphotericin B as preservatives.

- Transient soft tissue swelling may occur at the injection site.

- The use of this biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions.

Antidote

Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.

IN THE ABSENCE OF A VETERINARIAN-CLIENT-PATIENT RELATIONSHIP, U.S. FEDERAL REGULATIONS PROHIBIT THE RELABELING, REPACKAGING, RESALE, OR REDISTRIBUTION OF THE INDIVIDUAL CONTENTS OF THIS PACKAGE.

For veterinary use in dogs only.

U.S. Veterinary License No. 165A

Intervet Inc., Omaha, NE 68103 USA

1 800 224-5318 (USA)

1 888 306-0069 (Canada)

© 2009, Intervet Inc.

All rights reserved.

*Registered Trademark

	Code
25x1 DOSE	099895	P28100-11, P30601-10

Nac No.

10472951